REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer. [PDF]
Ng TL +20 more
europepmc +1 more source
Filgrastim after autologous stem cell transplantation shortens time to neutrophil recovery and hospital stay. [PDF]
Oosterink KA +7 more
europepmc +1 more source
The use of granulocyte colony-stimulating factors in the management of breast cancer patients. [PDF]
Bałata A +3 more
europepmc +1 more source
Healthy volunteer stem cell donors followed up 10 years after stimulation with biosimilar filgrastim. [PDF]
Heyn J +9 more
europepmc +1 more source
Poly-Infections in a Patient Living With Human Immunodeficiency Virus (HIV). [PDF]
Sorvillo AM +4 more
europepmc +1 more source
Factors influencing hospital length of stay in febrile neutropenia: A retrospective cohort study of Turkish patients with solid tumors. [PDF]
Cekin R, Senocak D, Cihan S.
europepmc +1 more source
Prophylactic Pegfilgrastim Versus On-Demand Filgrastim During Docetaxel and Cyclophosphamide Chemotherapy in Early-Stage Breast Cancer: A Retrospective Analysis. [PDF]
Banno H +9 more
europepmc +1 more source
Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients.
Riegler JS, Kesselheim AS, Rome BN.
europepmc +1 more source
Leflunomide-induced pancytopenia and agranulocytosis resulting in septic shock: A case report. [PDF]
Chang WH, Chien SC, Hu TY.
europepmc +1 more source

